SciVision Biotech Inc. (1786.TW)
- Previous Close
97.00 - Open
98.00 - Bid 96.20 x --
- Ask 96.40 x --
- Day's Range
96.00 - 98.10 - 52 Week Range
83.50 - 144.00 - Volume
290,978 - Avg. Volume
870,139 - Market Cap (intraday)
7.003B - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
28.63 - EPS (TTM)
3.36 - Earnings Date --
- Forward Dividend & Yield 3.24 (3.37%)
- Ex-Dividend Date Apr 25, 2025
- 1y Target Est
--
SciVision Biotech Inc. manufactures and sells hyaluronic acid medical products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in the wholesale of medical equipment; and provides management consulting services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.
www.scivision.com.twRecent News: 1786.TW
View MorePerformance Overview: 1786.TW
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1786.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1786.TW
View MoreValuation Measures
Market Cap
6.94B
Enterprise Value
6.19B
Trailing P/E
28.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.06
Price/Book (mrq)
4.00
Enterprise Value/Revenue
6.93
Enterprise Value/EBITDA
16.57
Financial Highlights
Profitability and Income Statement
Profit Margin
27.43%
Return on Assets (ttm)
6.87%
Return on Equity (ttm)
13.75%
Revenue (ttm)
883.31M
Net Income Avi to Common (ttm)
242.25M
Diluted EPS (ttm)
3.36
Balance Sheet and Cash Flow
Total Cash (mrq)
805.92M
Total Debt/Equity (mrq)
11.82%
Levered Free Cash Flow (ttm)
134.06M